Clinical Trial Update: A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients. [Phase 3]

View source ↗

Summary

A phase 3 randomized trial evaluated tacrolimus-minimisation with everolimus in new liver transplant recipients and followed renal function over 12 months; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant

Drugs mentioned

• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Liver Transplant | Phase 3 | Status: COMPLETED | Results posted: 2019-06-13